Fanny Pruvot
About Fanny Pruvot
Fanny Pruvot is the Eu Qppv and Director of Pharmacovigilance France at Bristol-Myers Squibb, with over 30 years of experience in the pharmaceutical industry.
Current Company
Fanny Pruvot is currently employed at Bristol-Myers Squibb in New Jersey, United States. She serves as the EU QPPV (Qualified Person for Pharmacovigilance) and Director of Pharmacovigilance for France. She has been with the company since December 2018.
Professional Title
Fanny Pruvot holds the title of EU QPPV and Director of Pharmacovigilance France at Bristol-Myers Squibb. Her role involves overseeing drug safety and ensuring compliance with regulatory requirements in pharmacovigilance.
Education and Expertise
Fanny Pruvot has a solid educational background in medicine and statistics. She earned a Doctor of Medicine degree from University Paris VI, where she studied from 1978 to 1986. She also studied Statistics at University Paris VI, from 1984 to 1986. Additionally, she attended Sorbonne Université from 2015 to 2019.
Industry Experience
With over 30 years of experience in the pharmaceutical industry, Fanny Pruvot has a diverse background that includes roles in clinical trial management and medical affairs. She worked as a Clinical Trial Project Manager at Cris for five years from 1989 to 1994. She also served as a Medical Affairs Manager at Laboratoires Grimberg Sa in Paris, Île-de-France, France, from 1986 to 1989.
Previous Positions
Before joining Bristol-Myers Squibb, Fanny Pruvot held several significant positions in the pharmaceutical sector. At Cris, she managed clinical trials as a Clinical Trial Project Manager from 1989 to 1994. Prior to that, she worked as a Medical Affairs Manager at Laboratoires Grimberg Sa from 1986 to 1989.